Lessons learned during the establishment of a functional National Public Health Institute in the Democratic Republic of Congo: from 2018 to 2024.

The Democratic Republic of Congo (DRC) experiences several disease outbreaks every year. In 2023 alone, the DRC faced outbreaks of Mpox, measles, yellow fever, vaccine-derived polio, malaria, and cholera, alongside humanitarian crises in some regions. Despite the expertise and experience in responding to such epidemics, the timely detection and response to public health emergencies remained a significant challenge, primarily due to challenges in coordination.

Cardiovascular Disease and Diabetes Are Among the Main Underlying Causes of Death in Twenty Healthcare Facilities Across Two Cities in the Democratic Republic of Congo.

Introduction: The mortality rates associated with cardiovascular disease (CVD) and diabetes exhibit disparities by region, with Central Africa ranking fourth globally in terms of mortality rate. The Democratic Republic of Congo (DRC) does not possess mortality data pertaining to these specific underlying causes of death. This study aimed to determine the death rate attributable to CVD and diabetes in two cities in the DRC.

Dynamic Progression of Hypertension and Diabetes in the Democratic Republic of Congo from 2019 to 2023.

The Democratic Republic of Congo (DRC) does not have national prevalence data for arterial hypertension (HTN) or diabetes (type I and II combined) to aid evidence-based decision-making, despite the assumption of epidemiological transition in low- and middle-income countries. The aim of this study was to estimate a proxy of prevalence for HTN and diabetes. This study used routine monthly reported data pertaining to HTN and diabetes from the District Health Information Software 2 (DHIS2), spanning 2019-2023.